Use access key #2 to skip to page content.
$2.45 0.25 (11.36%)
7/8/2008 4:00 PM

Cell Genesys, Inc. (CEGE)

CAPS Rating:
***

A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.

View All Commentary (CEGE)

Recs

0

Avatar KiminVT (25.63) Submitted: 4/24/08 4:37 PM : Outperform Start Price: $3.99 CEGE Score: -29.81

On the edge of breakthru technology for cancer

Report this Post Replies: 0 | Reply

Featured Broker Partners